Charles Nolan Parker
CIK: 0002125562
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Traws Pharma, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 9, 2026TRAW
Traws Pharma, Inc.
Award(A)DirectStock Option (right to buy)
90K shares- - Mar 8, 2026TRAW
Traws Pharma, Inc.
Award(A)DirectStock Option (right to buy)
104.5K shares- - Dec 12, 2025TRAW
Traws Pharma, Inc.
Award(A)Direct15.4K shares- - Oct 12, 2025TRAW
Traws Pharma, Inc.
Award(A)DirectStock Option (right to buy)
32.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 9, 2026 | TRAW Traws Pharma, Inc. | Award(A) Stock Option (right to buy) | 90,000 | - | - | Direct |
| Mar 8, 2026 | TRAW Traws Pharma, Inc. | Award(A) Stock Option (right to buy) | 104,544 | - | - | Direct |
| Dec 12, 2025 | TRAW Traws Pharma, Inc. | Award(A) | 15,393 | - | $0 | Direct |
| Oct 12, 2025 | TRAW Traws Pharma, Inc. | Award(A) Stock Option (right to buy) | 32,406 | - | - | Direct |
1-4 of 4 transactions
About Parker Charles Nolan
Parker Charles Nolan (SEC CIK 0002125562) files insider reports with the SEC as Chief Financial Officer of Traws Pharma, Inc. (TRAW).
Signal8 holds 3 ownership filings by Parker Charles Nolan (1 Form 3, 2 Form 4), filed between Apr 8, 2026 and Jul 14, 2026. Those filings report 4 transactions, from Oct 12, 2025 to Jul 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Parker Charles Nolan's filings is in NEWTOWN, PA.
Recent filings by Parker Charles Nolan
Other insiders filing for Traws Pharma, Inc. (TRAW)
- Pauza Charles David, Chief Science Officer Virology
- CAUTREELS WERNER, Director
- Savchuk Nikolay, Chief Operating Officer
- STOVER JACK E, Director
- Dukes Iain D., Chief Executive Officer
- Redfield Robert, Chief Medical Officer